利用人类诱导的多能干细胞来研究短QT综合征中的心房失常症
Assad Shiti1, Gil Arbil1, Naim Shaheen1
1Sohnis Family Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine, The Rappaport Faculty of Medicine and Research Institute, Technion - Israel Institute of Technology, Haifa, Israel.
Journal of molecular and cellular cardiology
|August 14, 2023
概括
研究人员创建了针对患者特定的人类心房细胞模型来治疗短QT综合征 (SQTS),这是心律失常的遗传原因. 这些模型有助于研究SQTS机制,并测试遗传性心房的潜在药物治疗方法.
科学领域:
- 心血管研究研究心血管研究
- 干细胞生物学 干细胞生物学
- 电子生理学 电子生理学
背景情况:
- 短QT综合征 (SQTS) 是一种罕见的,遗传的通道病变,导致心房和心室心律不整.
- 由于缺乏相关的人类心房组织模型,研究与SQTS相关的心房失常症是有限的.
研究的目的:
- 开发一种新的人类心房细胞和组织模型,用于研究与SQTS相关的心房失常症.
- 为了利用患者特异性诱导多能干细胞 (hiPSCs) 进行疾病建模.
主要方法:
- 使用基于视网膜酸的协议,将患者特异的hiPSC分化为心房肌细胞.
- 通过分子标记物和电生理学特性确认了心房身份.
- 创建了用于光学映射和药物测试的2D心房组织模型.
主要成果:
- SQTS-hiPSC心房心肌细胞表现出缩短的动作潜力和耐火期.
- 在SQTS模型中,光学映射显示了缩短的动作潜能持续时间和改变的螺旋波动力学.
- 奇尼丁和维纳卡兰特逆转了AP缩短和心律失常的不规则,与索塔洛尔不同.
结论:
- 为SQTS建立了基于患者特定的hiPSC的心房细胞和组织模型.
- 这些模型提供了对遗传性心房律不整的病原体的见解.
- 证明了这些模型对评估SQTS药理治疗的有用性.
更多相关视频
08:06Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization
Published on: January 17, 2020
7.9K
14:03High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
Published on: March 24, 2023
1.9K
相关概念视频
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Induced Pluripotent Stem Cells
24.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.2K
